Edition:
United States

Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

11.22USD
3:59pm EST
Change (% chg)

$0.86 (+8.30%)
Prev Close
$10.36
Open
$10.35
Day's High
$11.28
Day's Low
$10.35
Volume
594,332
Avg. Vol
413,097
52-wk High
$11.28
52-wk Low
$3.80

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

More From Around the Web

Name Age Since Current Position

Peter Crowley

57 2010 Independent Chairman of the Board

Mark Baker

60 2011 Chief Executive Officer, Director

Patrick Fabbio

48 2015 Chief Financial Officer

Nitya Ray

62 2004 Senior Vice President - Manufacturing

Vivien Wong

58 2013 Senior Vice President - Operations and Portfolio Management